Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.

The goal of this clinical trial is to retrospectively identify the most prevalent symptoms of genitourinary syndrome of menopause (GSM) among postmenopausal women and to evaluate their impact on quality of life. Moreover, based on data collected from medical records and/or patient-reported questionnaires, if available data enable it, it will be assessed whether treatment with the topical vulvovaginal gel XCM INTIM for a minimum of 8 weeks results in changes in symptom severity and in the impact of these symptoms across different quality-of-life domains.

NCT Number	NCT07737782
Lead Sponsor	Mucosa Innovations, S.L. Collaborators: Hospital Universitario La Luz Quirónsalud, Clínica Vilaboa
Conditions	Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause (GSM), Quality of Life, Menopause Related Conditions, Dyspareunia, Urinary Incontinence, Urgency-frequency, Sexual Function +2 more
Enrollment	100 participants
Start Date	2026-07
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-30